COMP <GO>
NATL vs TMO // FORWARD P/E MULTIPLE
NCR Atleos Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NATL 4
— TMO 8
▲ FORWARD P/E MULTIPLE LEADER: NATL
LAST: $45.71 (+0.93%) • MKT CAP: $3.38B
forward-pe
19.4x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NATL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NATL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.40% | 9.30% | +5.10 | NATL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | 30.4x | -20.70 | NATL | /valuation <GO> |
| Free Cash Flow Yield | 7.08% | 2.40% | +4.68 | NATL | /fcf-yield <GO> |
| Operating Margin | 11.00% | 17.40% | -6.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.70% | 15.10% | -11.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 3.90% | -2.80 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.49 | 4.50 | -3.01 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 62.9 | -16.90 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 19.4x | 36.3x | -16.90 | NATL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.38B | $262.22B | -$258.84B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NATL REV | TMO REV | NATL GROSS % | TMO GROSS % | NATL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.35B | $44.56B | — | — | $239.0M | $6.29B |
| FY 2024 | $4.30B | $42.88B | — | — | $257.0M | $7.27B |
| FY 2023 | $4.19B | $42.86B | — | — | $355.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NATL // BETA —
TMO // BETA 0.94